Menu

  • Products
  • MRI Information
  • Reimbursement
  • Medtronic Academy

    • Choice without limits

    Empowering clinicians to find the best treatment for every patient

    Education and training

    Access on-demand education and training materials.

    Visit Medtronic Academy (open in new window)
    Doctor works on computer

    Clinical evidence

    See how the Medtronic InterStim™ systems performed in treating overactive bladder and fecal incontinence.

    View evidence (open in new window)

    3 ×
    greater quality of life improvements

    The InterStim™ neurostimulation system delivered three times greater improvements in total quality of life for overactive bladder patients compared with medications.1,2

    Find important resources to support your practice.

    Father tosses son playfully into the air

    Resources

    Find marketing and publicity tools to support your practice's bladder and bowel control therapies.

    Access resources
    Woman looks at computer

    Reimbursement

    Find reimbursement coding and guidance for sacral neuromodulation and percutaneous tibial neuromodulation devices.

    Get information

    Featured rechargeable and recharge-free products

    InterStim™ advanced evaluation system

    The InterStim™ advanced evaluation system is a wearable neuromodulator with an electrode lead that helps patients track their bladder and bowel symptoms. 

    Meet the system

    InterStim X™ neurostimulation system

    InterStim X™ is a recharge-free sacral neurostimulator system that delivers therapy to restore† bowel and bladder control.

    Discover the system

    PTNM system

    The NURO™ system is an external neurostimulator that delivers percutaneous tibial neuromodulation (PTNM) to relieve symptoms caused by overactive bladder.

    See the product

    † Restored function defined as ≥50% reduction in dysfunctional voiding symptoms from baseline.

    1. Medtronic InterStim™ clinical summary 2018. 
    2. Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim™ therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230.